Clinical ink reposted this
✪ VP ▫️ Transformational Leader ▫️ Business Growth Strategy and Scaling ▫️ Life Science Business Development Innovation
If you missed our Webinar discussing solutions to unmet needs in GLP1 cardiometabolic clinical trials, please check out the recording.
Did you miss our webinar? Register now to watch the recording! Many thanks to the panel for this insightful conversation about solving unmet needs in #GLP1 #cardiometabolic #clinicaltrials. Moderator: Tom Dougherty, Data Science & AI Innovative Partnership Lead at Novo Nordisk, and Panelists: Jonathan Goldman, MD MBA ATP, CEO of Clinical ink, Kevin Dolgin, Co-Founder of Observia, Chris Bennani, Managing Director and Partner at Boston Consulting Group (BCG), Steve Polyak, Ph.D., Vice President, Engineering and Data at Clinical ink, and David Anderson, Principal Scientist at Clinical ink Register here: https://lnkd.in/eRfdjcpH